Laser zaps tooth pain: new study tests precision treatment
NCT ID NCT07287709
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a laser-based procedure to the standard method for treating severe toothache (irreversible pulpitis) in adult molars. Sixty participants will receive either laser or conventional treatment, and healing will be tracked using X-rays and AI analysis. The goal is to see if the laser approach is more effective at relieving pain and preserving the tooth.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Diode laser and sodium hypochlorite solution
- What this could lead to
- If successful, laser pulpotomy could offer a less painful, more precise alternative to standard root canal treatment for severe toothache.
- What could go wrong
- This is a small, early-stage trial with only 60 participants. The laser method may not prove more effective than the standard approach, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Permanent molar teeth with symptomatic irreversible pulpitis. * The patient should be ≥ 16 to 50 years old. * Teeth should give positive response to cold testing and clinical diagnosis of SIP with or without periapical rarefaction. * Teeth will be selected only if they are restorable. * Patient medically healthy and free from systemic diseases. ASA I, II. * patients who agreed to participate in the study to attend the control visits. * Teeth with periapical index score (PAI) 1 and 2 will be selected Exclusion Criteria: * Teeth with necrotic pulp, resorption or subgingival caries. * Teeth with open apices. * Medically compromised patients. * Pregnant patients. * Patients with uncontrollable bleeding from the radicular pulp. * Patients with (PAI) score 3-5 will be excluded from the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Irreversible pulpitis (toothache) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Faculty of Dentistry
RECRUITINGAlexandria, 21527, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.